Seattle, WA July 28, 2011–Mirador Biomedical, Inc., a medical device company focused on the development and commercialization of an innovative platform of point-of-access pressure monitoring devices, announced today that it has received CE Mark approval for its entire Compass™ platform as well as an ISO 13485 Quality Management System Certification.
The Compass™ is a single-use, inexpensive, digital pressure measurement device with integrated LCD designed to quickly and easily incorporate into procedural workflow, eliminating cumbersome cabling and capital equipment required by other solutions. The device provides confirmation and guidance for many common hospital procedures including:
- Vascular Access
- Lumbar Puncture
- Thoracentesis
- Paracentesis
- Compartment Syndrome Monitoring
- Arterial Access, and
- Epidural Anesthesia
“Point-of-Access pressure measurement can enhance the safety, speed, and ease of a wide variety of procedures. Unfortunately, current solutions increase procedural complexity and introduce opportunities for infection. The Compass™ offers the benefits of pressure monitoring without the complexity. This simplicity and safety is particularly important as physician extenders and procedure teams are increasingly performing these procedures,” said Dr. Justin Hulvershorn, Mirador’s Chief Science Officer.
The Compass™ Vascular Access and Compass™ Lumbar Puncture have been commercially available in the US since early 2011 and have been used in nearly 2,000 procedures at more than 50 hospitals.
“With US sales picking up briskly, we look forward to expanding our commercialization effort in the EU and introducing this novel device family to European physicians,” said Mirador CEO Karl Schmidt.
About the Compass™ Platform:
The Compass™ Vascular Access: attaches to standard needles and syringes during central venous, dialysis, port and sheath catheter insertion and provides pressure confirmation of needle tip, guidewire and catheter location. To help prevent devastating complications that arises from inadvertent arterial cannulations.
The Compass™ Lumbar Puncture: attaches to a spinal needle and provides an early indication of needle tip entrance into the CSF space and an instant opening pressure.
The Compass™ Thoracentesis: allows physicians to monitor pleural pressure, a key factor in optimizing fluid removal.
The Compass™ Compartment Syndrome: attaches to standard needles and syringes and provides an immediate compartment pressure reading.
The Compass™ Arterial Assist: attaches to standard needles and syringes and provides an instant indication of arterial access; optimization of the pressure waveform helps ensure successful guidewire and catheter introduction.
The Compass™ Epidural Assist: attaches to standard epidural needles and syringes and provides a visual loss-of-resistance.
About Mirador Biomedical
Mirador Biomedical’s team is collaborating with an exceptional group of physicians and scientists to develop and commercialize innovative, cost effective medical devices that alleviate doubt and uncertainty during common medical procedures.
Mirador Biomedical is a privately held company founded in 2009 in Seattle, Washington and has developed and is commercializing the Compass™ platform of medical devices. For more information, visit www.miradorbiomedical.com
